← Back to Search

Procedure

Minimally invasive aortic valve surgery for Minimally Invasive Cardiac Valve Surgery

N/A
Waitlist Available
Led By William Kent, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

The conventional approach to heart valve operations is through a sternotomy. This involves a vertical incision in the sternum (breastbone) to gain access to the heart and its related structures. Post-operative recovery after sternotomy can take anywhere from 6 weeks to 3 months due to the time required for the sternum to fully heal. Minimally invasive valve surgery is a less invasive alternative to conventional open-heart surgery. At the Foothills Medical Centre, surgeons perform minimally invasive valve surgery through a technique called right mini-thoracotomy. This involves a small incision on the right upper chest and leaves the sternum fully intact. It is unclear whether minimally invasive valve surgery provides better clinical outcomes and quality of life compared to conventional open heart surgery. The purpose of this research study is to compare the clinical outcomes of minimally invasive valve surgery via right mini-thoracotomy to conventional surgery via open-heart surgery. The results of this study will inform surgeons of the benefits and disadvantages of minimally invasive surgery compared to the current standards. This will help in developing better treatment strategies for patients requiring valve therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Health services resource usage
Perioperative outcomes
Post-operative analgesic use
+10 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Minimally invasive mitral valve surgeryExperimental Treatment1 Intervention
Patients undergoing minimally invasive mitral valve surgery
Group II: Minimally invasive aortic valve surgeryExperimental Treatment1 Intervention
Patients undergoing minimally invasive aortic valve surgery
Group III: Conventional aortic valve surgeryExperimental Treatment1 Intervention
Patients undergoing conventional aortic valve surgery

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
805 Previous Clinical Trials
883,912 Total Patients Enrolled
William Kent, MDPrincipal InvestigatorUniversity of Calgary
~25 spots leftby Sep 2025